A unique angiogenesis assay system that uses proprietary human ECMs and primary endothelial cells to capture and monitor the complex multi-stage, multi-step, process of stable micro- and large macrovessel formation in vitro. This system:
- Uses human ECMs precoated onto cell culture plates for immediate use.
- Produces highly stable micro- and macrovessels, with survival duration from weeks to months.
- Exhibits a unique, complex, multi-stage, multi-step vessel formation process.
Therapeutic Human Extracellular Matrix hECM
Product is in development.